BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2567175)

  • 1. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to glomerular antigens.
    Ronco P; Sahali D; Cittanova ML; van Leer EH; Chatelet F; Verroust P
    Nephrol Dial Transplant; 1992; 7 Suppl 1():9-15. PubMed ID: 1362802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Formation of immune deposits during experimental extramembranous glomerulonephritis].
    Verroust P; Ronco P
    Nephrologie; 1989; 10(3):123-6. PubMed ID: 2691908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
    Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.
    Hori MT; Abrass CK
    J Immunol; 1990 May; 144(10):3849-55. PubMed ID: 2185315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiopathogenesis of membranous nephropathy: is there a correlation between experimental and human pathology?].
    Allegri L; Celendo MT; Savazzi G; Garini G; Carnevali ML
    Ann Ital Med Int; 1989; 4(4):386-95. PubMed ID: 2487793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
    Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G
    J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis induced by rabbit antiserum to membrane antigens isolated from rat visceral yolk-sac microvilli.
    Leung CC; Cheewatrakoolpong B; O'Mara T; Black M
    Am J Anat; 1987 Jun; 179(2):169-74. PubMed ID: 3303894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
    Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
    Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
    Kerjaschki D
    Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubule brush border antigens: failure to confirm a pathogenetic role in human membranous glomerulonephritis.
    Thorpe LW; Cavallo T
    J Clin Lab Immunol; 1980 Mar; 3(2):125-7. PubMed ID: 7009872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
    Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
    J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Am J Pathol; 1985 Oct; 121(1):112-22. PubMed ID: 2413764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunopathologic study of a 330-kD protein defined by monoclonal antibodies and reactive with anti-RTE alpha 5 antibodies and kidney eluates from active Heymann nephritis.
    Ronco P; Neale TJ; Wilson CB; Galceran M; Verroust P
    J Immunol; 1986 Jan; 136(1):125-30. PubMed ID: 2415612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.